Recruiting studies: Invasive Breast Cancer Early Stages

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer
Phase 4 · 34 location(s) · Fudan University · NCT04790305 Endoscopy/Robotic Assisted Nipple Skin Sparing Mastectomy
Phase N/A · 1 location(s) · Alejandra García-Novoa · NCT06823414 CRYoablation for Small Tumors As Local Treatment - SIX Trial
Phase 3 · 2 location(s) · Hospital do Coracao · NCT06839001 Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer
Phase 2 · 1 location(s) · Yonsei University · NCT06677944 Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Recep
Phase 2 · 9 location(s) · Jonsson Comprehensive Cancer Center · NCT04553770 Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
NA · 1 location(s) · Thomas Jefferson University · NCT04959474 Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies
Phase N/A · 73 location(s) · Spanish Breast Cancer Research Group · NCT03390894 Radiation After No Axillary Nodal Sampling
NA · 1 location(s) · NYU Langone Health · NCT07723209 Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuv
Phase N/A · 1 location(s) · Emory University · NCT05877859 IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
Phase N/A · 1 location(s) · Mount Carmel Health System · NCT03536897 Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device
NA · 1 location(s) · ScreenCell · NCT06807502 Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
Phase 2 · 2 location(s) · Baylor Breast Care Center · NCT05020860 NabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer.
Phase N/A · 1 location(s) · Henan Cancer Hospital · NCT06781281 Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women
Phase 3 · 1 location(s) · RenJi Hospital · NCT03201861 Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
Phase 2 · 7 location(s) · Rutgers, The State University of New Jersey · NCT06518837 5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer
Phase 2 · 1 location(s) · University of Utah · NCT06961955 Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy
NA · 1 location(s) · HeroSupport SA · NCT07711847 Prospective Validation of Ataraxis AI Test for Predicting Treatment Response in Neoadjuvant Breast Cancer
Phase N/A · 1 location(s) · Young-Joon Kang · NCT07327970 Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Phase N/A · 745 location(s) · Alliance for Clinical Trials in Oncology · NCT05334069 BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer
Phase 2 · 1 location(s) · University of Illinois at Chicago · NCT04891068 The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast
NA · 20 location(s) · Du Zhenggui · NCT06995118

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.